i-CBT and IV Ketamine for Suicidality in Treatment-Resistant Depression: A Randomized, Midazolam-Controlled Clinical Trial

Abroad (travel likely)RecruitingPHASE2

Conditions

Major Depressive Disorder · Suicide · Treatment Resistant Depression

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Toronto General Hospital, Toronto, Ontario, Canada
Contact: Study coordinator (Simryn Selby) · simryn.selby@uhn.ca
Contact: Principal Investigator (Rodrigo Mansur, MD)

Study leads

Rodrigo Mansur
Principal Investigator
University Health Network, Toronto

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Ketamine Augmentation of ECT in Treatment-Resistant Depression

Major Depressive Disorder · Treatment Resistant Depression

Abroad (travel likely)RecruitingPHASE3

Milan, Italy

Feasibility and Acceptability of an E-learning Dialectical Behavior Therapy Skills Course

Depression - Major Depressive Disorder · Anxiety · Depression

Abroad (travel likely)Recruiting

Windsor, Canada

Maintenance rTMS for Depression (Maitr-De)

Major Depressive Disorder · Treatment Resistant Depression

Abroad (travel likely)Recruiting

San Diego, United States · New York, United States

Fluoxetine on Emotional Experience (FLEX) Study

Depression - Major Depressive Disorder · Irritability · Depression

Abroad (travel likely)Recruiting

Oxford, United Kingdom